Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

A bihormonal closed-loop artificial pancreas for type 1 diabetes.

El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER.

Sci Transl Med. 2010 Apr 14;2(27):27ra27. doi: 10.1126/scitranslmed.3000619.

PMID:
20393188
[PubMed - indexed for MEDLINE]
Free Article
2.

Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes.

Castle JR, Engle JM, El Youssef J, Massoud RG, Yuen KC, Kagan R, Ward WK.

Diabetes Care. 2010 Jun;33(6):1282-7. doi: 10.2337/dc09-2254. Epub 2010 Mar 23.

PMID:
20332355
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

An analysis of the SEVEN system: have we reached the summit of needle-type sensor accuracy?

Wentholt IM, DeVries JH.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1155-7.

PMID:
20144430
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Progress in development of an artificial pancreas.

Klonoff DC, Cobelli C, Kovatchev B, Zisser HC.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1002-4.

PMID:
20144412
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB.

Lancet. 2010 Feb 27;375(9716):743-51. doi: 10.1016/S0140-6736(09)61998-X. Epub 2010 Feb 4.

PMID:
20138357
[PubMed - indexed for MEDLINE]
Free Article
6.

Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems.

Garg SK, Smith J, Beatson C, Lopez-Baca B, Voelmle M, Gottlieb PA.

Diabetes Technol Ther. 2009 Feb;11(2):65-72. doi: 10.1089/dia.2008.0109. Erratum in: Diabetes Technol Ther. 2009 Mar;11(3):205.

PMID:
19243265
[PubMed - indexed for MEDLINE]
7.

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.

Diabetes Care. 2008 May;31(5):934-9. doi: 10.2337/dc07-1967. Epub 2008 Feb 5.

PMID:
18252903
[PubMed - indexed for MEDLINE]
8.

Study of the effects of tissue reactions on the function of implanted glucose sensors.

Dungel P, Long N, Yu B, Moussy Y, Moussy F.

J Biomed Mater Res A. 2008 Jun 1;85(3):699-706.

PMID:
17876777
[PubMed - indexed for MEDLINE]
9.

Feasibility of automating insulin delivery for the treatment of type 1 diabetes.

Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF.

Diabetes. 2006 Dec;55(12):3344-50.

PMID:
17130478
[PubMed - indexed for MEDLINE]
Free Article
10.

Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment.

Holmes G, Galitz L, Hu P, Lyness W.

Br J Clin Pharmacol. 2005 Nov;60(5):469-76.

PMID:
16236036
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A novel insulin delivery algorithm in rats with type 1 diabetes: the fading memory proportional-derivative method.

Gopakumaran B, Duman HM, Overholser DP, Federiuk IF, Quinn MJ, Wood MD, Ward WK.

Artif Organs. 2005 Aug;29(8):599-607.

PMID:
16048475
[PubMed - indexed for MEDLINE]
12.

Automation control of blood sugar a servomechanism for glucose monitoring and control.

KADISH AH.

Trans Am Soc Artif Intern Organs. 1963;9:363-7. No abstract available.

PMID:
13958209
[PubMed - indexed for MEDLINE]
13.

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.

Cryer PE.

Diabetologia. 2002 Jul;45(7):937-48. Epub 2002 Apr 26. Review.

PMID:
12136392
[PubMed - indexed for MEDLINE]
14.

Clinical pharmacokinetics and pharmacodynamics of insulin aspart.

Lindholm A, Jacobsen LV.

Clin Pharmacokinet. 2001;40(9):641-59. Review.

PMID:
11605714
[PubMed - indexed for MEDLINE]
15.

Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes.

Bischof MG, Krssak M, Krebs M, Bernroider E, Stingl H, Waldhäusl W, Roden M.

Diabetes. 2001 Feb;50(2):392-8.

PMID:
11272152
[PubMed - indexed for MEDLINE]
Free Article
16.

Pharmacokinetics of intranasal, intramuscular and intravenous glucagon in healthy subjects and diabetic patients.

Pontiroli AE, Calderara A, Perfetti MG, Bareggi SR.

Eur J Clin Pharmacol. 1993;45(6):555-8.

PMID:
8157042
[PubMed - indexed for MEDLINE]
18.

Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes.

Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS.

Ann Intern Med. 1985 Aug;103(2):184-90.

PMID:
3893253
[PubMed - indexed for MEDLINE]
19.

Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.

Orskov L, Alberti KG, Mengel A, Møller N, Pedersen O, Rasmussen O, Seefeldt T, Schmitz O.

Diabetologia. 1991 Jul;34(7):521-6.

PMID:
1916058
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk